The Securities and Exchange Board of India (Sebi) is set to review its mutual fund and stock broker regulations next month. Key proposals include unbundling broking fees and updating stock broker rules, which were framed 30 years ago. Sebi aims to streamline compliance and enhance ease of doing business.
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details
Wockhardt’s shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections. The drug, combining cefepime and zidebactam,